EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,405 | +7.3% | 7,560 | +16.9% | 0.00% | – |
| Q2 2023 | $56,272 | -94.3% | 6,468 | -98.1% | 0.00% | – |
| Q1 2023 | $983,024 | -17.1% | 334,362 | -1.3% | 0.00% | – |
| Q4 2022 | $1,185,086 | +1419.3% | 338,596 | +3306.1% | 0.00% | – |
| Q3 2022 | $78,000 | +18.2% | 9,941 | +19.7% | 0.00% | – |
| Q2 2022 | $66,000 | -37.1% | 8,302 | -4.5% | 0.00% | – |
| Q1 2022 | $105,000 | -88.7% | 8,689 | -88.5% | 0.00% | – |
| Q4 2021 | $928,000 | +654.5% | 75,800 | +541.4% | 0.00% | – |
| Q3 2021 | $123,000 | +141.2% | 11,818 | +107.6% | 0.00% | – |
| Q2 2021 | $51,000 | -26.1% | 5,694 | -16.3% | 0.00% | – |
| Q1 2021 | $69,000 | – | 6,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |